Provided by Tiger Trade Technology Pte. Ltd.

Integra Lifesciences

12.68
-3.4100-21.19%
Post-market: 12.890.2100+1.66%19:54 EDT
Volume:2.70M
Turnover:35.11M
Market Cap:987.67M
PE:-136.17
High:14.00
Open:13.31
Low:12.63
Close:16.09
52wk High:20.49
52wk Low:8.70
Shares:77.89M
Float Shares:58.67M
Volume Ratio:3.91
T/O Rate:4.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0931
EPS(LYR):-6.7400
ROE:-0.70%
ROA:2.82%
PB:0.95
PE(LYR):-1.88

Loading ...

Integra Lifesciences Q1 Adj. EPS $0.54 Beats $0.41 Estimate, Sales $391.918M Beat $381.870M Estimate

Benzinga Earnings
·
May 05

BRIEF-Integra Lifesciences Announces Leadership Transition

Reuters
·
May 05

Integra LifeSciences Q1 FY26 adjusted EPS rises 31.7% to 0.54; revenue increases 2.4% to 391.9 million

Reuters
·
May 05

BRIEF-Integra Lifesciences Q1 Adjusted EPS USD 0.54 Vs. IBES Estimate USD 0.4

Reuters
·
May 05

Integra names board chair Stuart Essig as CEO, replacing Mojdeh Poul

Reuters
·
May 05

Integra Lifesciences Q1 Adjusted Ebitda USD 76.2 Million

THOMSON REUTERS
·
May 05

Integra Lifesciences Q1 Adjusted Gross Margin 64.1%

THOMSON REUTERS
·
May 05

Integra Lifesciences Outlook FY Adjusted EPS USD 2.4-2.5

THOMSON REUTERS
·
May 05

Integra Lifesciences Outlook Q2 Revenue USD 410-425 Million

THOMSON REUTERS
·
May 05

Integra Lifesciences Outlook Q2 Adjusted EPS USD 0.44 -0.52

THOMSON REUTERS
·
May 05

Integra Lifesciences Holdings Corp - Stuart Essig Succeeds Mojdeh Poul as President and CEO

THOMSON REUTERS
·
May 05

Integra Lifesciences Holdings Corp - Appoints Stuart Essig as President and CEO

THOMSON REUTERS
·
May 05

Press Release: Integra LifeSciences Announces Leadership Transition

Dow Jones
·
May 05

Top News Today/Canada: Government Pledges Additional C$1.5 Billion for Manufacturers

Dow Jones
·
May 05

Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026

GlobeNewswire
·
Apr 20

Integra LifeSciences extends $150 million receivables facility maturity to 2029

Reuters
·
Apr 16

Integra LifeSciences price target lowered to $12 from $13 at Truist

TIPRANKS
·
Apr 15

Truist Cuts Price Target on Integra LifeSciences Holdings to $12 From $13, Keeps Hold Rating

MT Newswires Live
·
Apr 15

Integra LifeSciences Cut to Hold From Buy by Argus Research

Dow Jones
·
Apr 15

Integra Lifesciences Holdings Corp : Argus Research Cuts to Hold From Buy

THOMSON REUTERS
·
Apr 15